JP Patent
JP6086528B2 — 長期のインビボ有効性を有する成長ホルモン
Assigned to ノヴォ・ノルディスク・ヘルス・ケア・アーゲー · Expires 2017-03-01 · 9y expired
What this patent protects
Patent listed against Ozempic.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.